Jin Zhang

6PUBLICATIONS
34CO-AUTHORS
Gene and molecular therapyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.

|Feb 12, 2026
A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents.

Jingjing Liu, Yuyun Wang, Xiaotong Xu

|Jun 21, 2024
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial.

Wenjia Zuo, Zhonghua Wang, Jun Qian

|Dec 15, 2022
Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer.

Shaorong Zhao, Teng Pan, Jinhai Deng

|Jun 26, 2021
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer.

Yufan Qiu, Yi Yang, Riyao Yang

|Feb 02, 2021
T-cell receptors provide potential prognostic signatures for breast cancer.

Jingjing Liu, Jin Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Yufan Qiu

1 joint publications

Riyao Yang

1 joint publications

Mien-Chie Hung

1 joint publications

Tony Ng